Kyle Fetchko

Director, Financial Planning & Analysis at XyloCor Therapeutics

Kyle Fetchko brings over a decade of experience in Financial Planning & Analysis, supporting both clinical‑stage and commercial businesses in addition to providing strategic analysis for both small and global organizations. Most recently, he held finance positions at Arch Oncology and Novocure. He holds an MBA from Villanova University specializing in Strategic Management & Data Analytics.